The results demonstrated that both the CD4+ and CD8+ T cell subsets in the BM of DN AML patients possessed a higher percentage of PD-1 (Figure 3A) and TIGIT (Figure 3B) when compared with corresponding PB, and the increase in the CD8+ population was most apparent. The gene discussed is CD8A; the disease is acute myeloid leukemia.